ALTIMI - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Image for trademark with serial number 88304845
Serial Number
88304845
Word Mark
ALTIMI
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2021-09-19
Filing Date
2019-02-17
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2020-12-15
Law Office Assigned Location Code
M50
Employee Name
BECHHOFER, YOCHEVED D
Statements
Goods and Services
House mark for a full line of pharmaceuticals and pharmaceutical preparations, namely, pharmaceutical preparations and substances used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, dermatological, pulmonary, respiratory, oncological, hepatological, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, endocrine, neurological, sleep, muscular, and psychiatric diseases and disorders;pharmaceutical preparations and substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, polymyalgia rheumatic, spondyloarthropathies, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, autoimmune pancreatitis, multiple myeloma, multiple sclerosis, systemic lupus erythematosus, lupus nephritis, chronic inflammatory demyelinating polyneuropathy, autoimmune anemia, autoimmune hemolytic anemia, pure red cell aplasia, idiopathic thrombocytopenic purpura, Evans syndrome, type 1 diabetes mellitus, Sjogren's syndrome, encephalitis, IgG4-related disease, Devic's disease, myositis, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, palmoplantar psoriasis, hidradenitis suppurativa, bullous skin disorder, pemphigus, pemphigoid, kawasaki disease, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, age-related macular degeneration, refractory diabetic macular edema, uveitis, childhood uveitis, uveitic macular edema, choroidal neovascularization, Graves' ophthalmopathy, pyoderma gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancer, breast cancer, ovarian cancer, cervical cancer, gastric cancer, colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, head and neck cancer, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, lymphocyte predominant subtype of Hodgkin's Lymphoma, vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, graft-versus-host disease, graft-versus-host disease following allogenic hematopoietic stem cell transplantation, graft-versus-host disease following keratoprosthesis, kidney transplant, asthma, chronic fatigue syndrome, major depression, and bipolar depression
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-03-10
Primary Code
005
First Use Anywhere Date
2020-07-01
First Use In Commerce Date
2020-07-01
Correspondences
Name
Altimi Biosciences, Inc.
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2019-02-20NEW APPLICATION ENTERED IN TRAM
2019-03-10NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-04-29ASSIGNED TO EXAMINER
2019-04-29SUSPENSION LETTER WRITTEN
2019-04-29LETTER OF SUSPENSION E-MAILED
2019-04-29NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2019-11-03REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
2020-05-10REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
2020-11-10APPROVED FOR PUB - PRINCIPAL REGISTER
2020-11-25NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-12-15PUBLISHED FOR OPPOSITION
2020-12-15OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-02-09NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2021-02-10TEAS STATEMENT OF USE RECEIVED
2021-03-01CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-02-10USE AMENDMENT FILED
2021-03-02STATEMENT OF USE PROCESSING COMPLETE
2021-03-07SU - NON-FINAL ACTION - WRITTEN
2021-03-07NON-FINAL ACTION E-MAILED
2021-03-07NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-09-19ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
2021-09-20ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND